| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Feb―04 |
Defining the mechanism of cross-reactivity for a SARS-CoV-2 Beta-elicited antibody toward omicron sub-lineages |
Frances Ayres, Bronwen Lambson, Nonhlanhla N. Mkhize, Zanele Makhado, Donald Mhlanga, Rudolph Serage, Penny L. Moore, Constantinos Kurt Wibmer, Thandeka Moyo-Gwete |
| 2 |
[GO] |
2025―Jul―25 |
Cross-species recognition of squirrel ACE2 by the receptor binding domains of SARS-CoV-2, RaTG13, PCoV-GD and PCoV-GX |
Chenghai Wang, Xiaoyan Nan, Yang Deng, Shilong Fan, Jun Lan |
| 3 |
[GO] |
2025―Apr―29 |
A distinctive IGHV3-66 SARS-CoV-2 neutralizing antibody elicited by primary infection with an Omicron variant |
Qing Fan, Congcong Liu, Huimin Guo, Shilong Tang, Haiyan Wang, Bing Zhou, Yuehong Sun, Miao Wang, Xiangyang Ge, Lei Liu, Bin Ju, Zheng Zhang |
| 4 |
[GO] |
2025―Apr―29 |
Structural insights into the receptor-binding domain of bat coronavirus ZXC21 |
Chenghai Wang, Xiaoyan Nan, Yang Deng, Shilong Fan, Xin Li, Jun Lan |
| 5 |
[GO] |
2025―Apr―11 |
Structural insights into the assembly and regulation of 2′-O RNA methylation by SARS-CoV-2 nsp16/nsp10 |
Anurag Misra, R. Rahisuddin, Manish Parihar, Shailee Arya, Thiruselvam Viswanathan, Nathaniel Jackson, Shan Qi, Siu-Hong Chan, Reuben S. Harris, Luis Martinez-Sobrido, Yogesh K. Gupta |
| 6 |
[GO] |
2024―Nov―13 |
The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity |
María Ángeles Márquez-Moñino, Clara M. Santiveri, Patricia de León, Sergio Camero, Ramón Campos-Olivas, M. Ángeles Jiménez, Margarita Sáiz, Beatriz González, José Manuel Pérez-Cañadillas |
| 7 |
[GO] |
2024―Nov―07 |
Multi-step shapeshifting of SARS-CoV-2 Omicron spikes during fusion |
Wang Xu, Yang Han, Maolin Lu |
| 8 |
[GO] |
2024―Okt―31 |
Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution |
Shuvankar Dey, Purba Pahari, Srija Mukherjee, James B. Munro, Dibyendu Kumar Das |
| 9 |
[GO] |
2024―Okt―03 |
Conformational dynamics of SARS-CoV-2 Omicron spike trimers during fusion activation at single molecule resolution |
Shuvankar Dey, Purba Pahari, Srija Mukherjee, James B. Munro, Dibyendu Kumar Das |
| 10 |
[GO] |
2024―Sep―06 |
Structural review of SARS-CoV-2 antiviral targets |
Wen Cui, Yinkai Duan, Yan Gao, Wei Wang, Haitao Yang |
| 11 |
[GO] |
2024―Aug―22 |
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike |
Helen M.E. Duyvesteyn, Aiste Dijokaite-Guraliuc, Chang Liu, Piyada Supasa, Barbara Kronsteiner, Katie Jeffery, Lizzie Stafford, Paul Klenerman, Susanna J. Dunachie, Juthathip Mongkolsapaya, Elizabeth E. Fry, Jingshan Ren, David I. Stuart, Gavin R. Screaton |
| 12 |
[GO] |
2024―Jul―15 |
Spike structures, receptor binding, and immune escape of recently circulating SARS-CoV-2 Omicron BA.2.86, JN.1, EG.5, EG.5.1, and HV.1 sub-variants |
Linjie Li, Kaiyuan Shi, Yuhang Gu, Zepeng Xu, Chang Shu, Dedong Li, Junqing Sun, Mengqing Cong, Xiaomei Li, Xin Zhao, Guanghui Yu, Songnian Hu, Hui Tan, Jianxun Qi, Xiaopeng Ma, Kefang Liu, George F. Gao |
| 13 |
[GO] |
2024―Jun―25 |
De novo design of SARS-CoV-2 main protease inhibitors with characteristic binding modes |
Yan Zhu, Jiaolong Meng, Bo Feng, Yao Zhao, Yi Zang, Lingling Lu, Mingbo Su, Qi Yang, Qi Zhang, Lu Feng, Jinyi Zhao, Maolin Shao, Yuanyuan Ma, Xiuna Yang, Haitao Yang, Jia Li, Xuefeng Jiang, Zihe Rao |
| 14 |
[GO] |
2024―Jan―15 |
Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1 |
Tatsuhiko Ozawa, Yoshiki Ikeda, Liuan Chen, Rigel Suzuki, Atsushi Hoshino, Akira Noguchi, Shunsuke Kita, Yuki Anraku, Emiko Igarashi, Yumiko Saga, Noriko Inasaki, Shunta Taminishi, Jiei Sasaki, Yuhei Kirita, Hideo Fukuhara, Katsumi Maenaka, Takao Hashiguchi, Takasuke Fukuhara, Kenichi Hirabayashi, Hideki Tani, Hiroyuki Kishi, Hideki Niimi |
| 15 |
[GO] |
2023―Dez―28 |
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain |
Rajeshwer S. Sankhala, Vincent Dussupt, Wei-Hung Chen, Hongjun Bai, Elizabeth J. Martinez, Jaime L. Jensen, Phyllis A. Rees, Agnes Hajduczki, William C. Chang, Misook Choe, Lianying Yan, Spencer L. Sterling, Isabella Swafford, Caitlin Kuklis, Sandrine Soman, Jocelyn King, Courtney Corbitt, Michelle Zemil, Caroline E. Peterson, Letzibeth Mendez-Rivera, Samantha M. Townsley, Gina C. Donofrio, Kerri G. Lal, Ursula Tran, Ethan C. Green, Clayton Smith, Natalia de Val, Eric D. Laing, Christopher C. Broder, Jeffrey R. Currier, Gregory D. Gromowski, Lindsay Wieczorek, Morgane Rolland, Dominic Paquin-Proulx, Dewald van Dyk, Zachary Britton, Saravanan Rajan, Yueh Ming Loo, Patrick M. McTamney, Mark T. Esser, Victoria R. Polonis, Nelson L. Michael, Shelly J. Krebs, Kayvon Modjarrad, M. Gordon Joyce |
| 16 |
[GO] |
2023―Okt―27 |
Review of serial femtosecond crystallography including the COVID-19 pandemic impact and future outlook |
Sabine Botha, Petra Fromme |
| 17 |
[GO] |
2023―Aug―24 |
SARS-CoV-2 fusion peptide sculpting of a membrane with insertion of charged and polar groups |
Steven R. Van Doren, Benjamin S. Scott, Rama K. Koppisetti |
| 18 |
[GO] |
2023―Jul―06 |
Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variant |
Meng Yuan, Ian A. Wilson |
| 19 |
[GO] |
2023―Mai―11 |
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response |
Anamika Patel, Sanjeev Kumar, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Elluri Seetharami Reddy, Kamalvishnu Gottimukkala, Prashant Bajpai, Dinesh Ravindra Raju, Venkata Viswanadh Edara, Meredith E. Davis-Gardner, Susanne Linderman, Kritika Dixit, Pragati Sharma, Grace Mantus, Narayanaiah Cheedarla, Hans P. Verkerke, Filipp Frank, Andrew S. Neish, John D. Roback, Carl W. Davis, Jens Wrammert, Rafi Ahmed, Mehul S. Suthar, Amit Sharma, Kaja Murali-Krishna, Anmol Chandele, Eric A. Ortlund |
| 20 |
[GO] |
2023―Mrz―03 |
Molecular architecture and dynamics of SARS-CoV-2 envelope by integrative modeling |
Weria Pezeshkian, Fabian Grünewald, Oleksandr Narykov, Senbao Lu, Valeria Arkhipova, Alexey Solodovnikov, Tsjerk A. Wassenaar, Siewert J. Marrink, Dmitry Korkin |
| 21 |
[GO] |
2023―Feb―02 |
Order and disorder bound together in SARS-CoV-2 Nsp1 suppress host translation |
David S. Libich, Antoine Baudin |
| 22 |
[GO] |
2023―Jan―10 |
Room-temperature structural studies of SARS-CoV-2 protein NendoU with an X-ray free-electron laser |
Rebecca J. Jernigan, Dhenugen Logeswaran, Diandra Doppler, Nirupa Nagaratnam, Mukul Sonker, Jay-How Yang, Gihan Ketawala, Jose M. Martin-Garcia, Megan L. Shelby, Thomas D. Grant, Valerio Mariani, Alexandra Tolstikova, Michelle Z. Sheikh, Mimi Cho Yung, Matthew A. Coleman, Sahba Zaare, Emily K. Kaschner, Mohammad Towshif Rabbani, Reza Nazari, Michele A. Zacks, Brandon Hayes, Raymond G. Sierra, Mark S. Hunter, Stella Lisova, Alexander Batyuk, Christopher Kupitz, Sebastien Boutet, Debra T. Hansen, Richard A. Kirian, Marius Schmidt, Raimund Fromme, Matthias Frank, Alexandra Ros, Julian J.-L. Chen, Sabine Botha, Petra Fromme |
| 23 |
[GO] |
2023―Jan―06 |
Structural insights into the activity regulation of full-length non-structural protein 1 from SARS-CoV-2 |
Ying Wang, John Kirkpatrick, Susanne zur Lage, Teresa Carlomagno |
| 24 |
[GO] |
2022―Okt―06 |
Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2 |
Philipp Nawrath, Antoni G. Wrobel |
| 25 |
[GO] |
2022―Aug―01 |
Structural insights into the binding of SARS-CoV-2, SARS-CoV, and hCoV-NL63 spike receptor-binding domain to horse ACE2 |
Jun Lan, Peng Chen, Weiming Liu, Wenlin Ren, Linqi Zhang, Qiang Ding, Qi Zhang, Xinquan Wang, Jiwan Ge |
| 26 |
[GO] |
2022―Jun―17 |
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection |
Kendra R. Vann, Arpan Acharya, Suk Min Jang, Catherine Lachance, Mohamad Zandian, Tina A. Holt, Audrey L. Smith, Kabita Pandey, Donald L. Durden, Dalia El-Gamal, Jacques Côté, Siddappa N. Byrareddy, Tatiana G. Kutateladze |
| 27 |
[GO] |
2022―Jun―03 |
Uncovering cryptic pockets in the SARS-CoV-2 spike glycoprotein |
Lorena Zuzic, Firdaus Samsudin, Aishwary T. Shivgan, Palur V. Raghuvamsi, Jan K. Marzinek, Alister Boags, Conrado Pedebos, Nikhil K. Tulsian, Jim Warwicker, Paul MacAry, Max Crispin, Syma Khalid, Ganesh S. Anand, Peter J. Bond |
| 28 |
[GO] |
2022―Mai―23 |
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity |
Anna Czarna, Jacek Plewka, Leanid Kresik, Alex Matsuda, Abdulkarim Karim, Colin Robinson, Sean O’Byrne, Fraser Cunningham, Irene Georgiou, Piotr Wilk, Magdalena Pachota, Grzegorz Popowicz, Paul Graham Wyatt, Grzegorz Dubin, Krzysztof Pyrć |
| 29 |
[GO] |
2022―Mrz―10 |
Structural basis of nanobodies neutralizing SARS-CoV-2 variants |
Zhenzhong Shi, Xiyang Li, Lu Wang, Zengchao Sun, Haiwei Zhang, Xiaochen Chen, Qianqian Cui, Huarui Qiao, Zhongyun Lan, Xin Zhang, Xianheng Li, Lingyun Li, Jianfeng Xu, Rui Gong, Chengpeng Fan, Yong Geng |
| 30 |
[GO] |
2022―Jan―20 |
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein |
Zhen Wah Tan, Wei-Ven Tee, Firdaus Samsudin, Enrico Guarnera, Peter J. Bond, Igor N. Berezovsky |
| 31 |
[GO] |
2021―Aug―16 |
Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing |
Serdar Durdagi, Çağdaş Dağ, Berna Dogan, Merve Yigin, Timucin Avsar, Cengizhan Buyukdag, Ismail Erol, Fatma Betul Ertem, Seyma Calis, Gunseli Yildirim, Muge D. Orhan, Omur Guven, Busecan Aksoydan, Ebru Destan, Kader Sahin, Sabri O. Besler, Lalehan Oktay, Alaleh Shafiei, Ilayda Tolu, Esra Ayan, Busra Yuksel, Ayse B. Peksen, Oktay Gocenler, Ali D. Yucel, Ozgur Can, Serena Ozabrahamyan, Alpsu Olkan, Ece Erdemoglu, Fulya Aksit, Gokhan Tanisali, Oleksandr M. Yefanov, Anton Barty, Alexandra Tolstikova, Gihan K. Ketawala, Sabine Botha, E. Han Dao, Brandon Hayes, Mengning Liang, Matthew H. Seaberg, Mark S. Hunter, Alex Batyuk, Valerio Mariani, Zhen Su, Frederic Poitevin, Chun Hong Yoon, Christopher Kupitz, Raymond G. Sierra, Edward H. Snell, Hasan DeMirci |
| 32 |
[GO] |
2021―Jun―22 |
Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease |
Maya G. Deshmukh, Joseph A. Ippolito, Chun-Hui Zhang, Elizabeth A. Stone, Raquel A. Reilly, Scott J. Miller, William L. Jorgensen, Karen S. Anderson |
| 33 |
[GO] |
2021―Jun―09 |
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies |
Gabriele Cerutti, Micah Rapp, Yicheng Guo, Fabiana Bahna, Jude Bimela, Eswar R. Reddem, Jian Yu, Pengfei Wang, Lihong Liu, Yaoxing Huang, David D. Ho, Peter D. Kwong, Zizhang Sheng, Lawrence Shapiro |
| 34 |
[GO] |
2021―Apr―30 |
Conformational flexibility and structural variability of SARS-CoV2 S protein |
Ishika Pramanick, Nayanika Sengupta, Suman Mishra, Suman Pandey, Nidhi Girish, Alakta Das, Somnath Dutta |
| 35 |
[GO] |
2021―Apr―29 |
A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro |
Mary Hongying Cheng, Rebecca A. Porritt, Magali Noval Rivas, James M. Krieger, Asli Beyza Ozdemir, Gustavo Garcia, Vaithilingaraja Arumugaswami, Bettina C. Fries, Moshe Arditi, Ivet Bahar |
| 36 |
[GO] |
2020―Okt―23 |
Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals |
Daniel W. Kneller, Stephanie Galanie, Gwyndalyn Phillips, Hugh M. O'Neill, Leighton Coates, Andrey Kovalevsky |
| 37 |
[GO] |
2020―Okt―15 |
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET |
Chuang Liu, Luiza Mendonça, Yang Yang, Yuanzhu Gao, Chenguang Shen, Jiwei Liu, Tao Ni, Bin Ju, Congcong Liu, Xian Tang, Jinli Wei, Xiaomin Ma, Yanan Zhu, Weilong Liu, Shuman Xu, Yingxia Liu, Jing Yuan, Jing Wu, Zheng Liu, Zheng Zhang, Lei Liu, Peiyi Wang, Peijun Zhang |
| 38 |
[GO] |
2020―Aug―04 |
Structure of the Pandemic |
Sarah Kearns |
|
